Covid-19 and Semi-Periphery

Abstract

The SARS-CoV-2 pandemic has disturbed the order of the world-system. While central countries—through their pharmaceutical multinationals—focused on the development of vaccines, semi-peripheral and peripheral countries fulfill another role, either by offering an environment for trials, or by inserting themselves in the hierarchical global order as a hub for research, development, or production of the candidate vaccines. This paper focuses on the analysis of the geopolitics of the world-system regarding production and participation in the clinical trials of vaccines for SARS-CoV-2 of Oxford University-AstraZeneca, BioNTech-Pfizer, and Sinopharm in Argentina. This is a case analysis of the Argentine semi-peripheral context, the local and global pharmaceutical industry, and the geopolitical order. We conclude that Argentina, which has scientific and industrial capabilities to manufacture vaccines, has joined in global value chains on the dependence side, deepening the scientific and technological gap vis-à-vis the central countries.

Keywords

• geopolitics
• semi-periphery
• global value chains
• vaccines
• Covid-19
• Big Pharma